The FDA has approved Tryngolza (olezarsen) to reduce triglycerides and acute pancreatitis risk in adults with severe hypertriglyceridemia (TG ≥500mg/dL).
Objectives Elective non-emergent surgical wait times have increased across countries such as Canada, straining operating room ...
An analytical report on how high-performing companies use productivity, talent, technology, and operating models to build ...